logo

For the Inventor, By the Inventor

Texas City, TX, United States of America

Amarnath Natarajan

This inventor holds 6 USPTO granted patents. Top assignee: Harvard College. Active years: 2010-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amarnath Natarajan. Retrieved from https://idiyas.com/inventor/amarnath-natarajan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:

goldMedal6 out of 3,075 
 
Harvard College
 patents

Years Active: 2010-2013

Loading Chart...
6 patents (USPTO):Explore Patents
1. 8354440 - 3-3-di-substituted-oxindoles as inhibitors of translation initiation (2013-01-15),
2. 8268879 - 3-3-di-substituted-oxindoles as inhibitors of translation initiation (2012-09-18),
3. 8088816 - 3-3-di-substituted-oxindoles as inhibitors of translation initiation (2012-01-03),
4. 8044089 - 3-3-di-substituted-oxindoles as inhibitors of translation initiation (2011-10-25),
5. 7846962 - 3-3-di-substituted-oxindoles as inhibitors of translation initiation (2010-12-07),
6. 7737172 - 3-3-di-substituted-oxindoles as inhibitors of translation initiation (2010-06-15),

Title: Amarnath Natarajan: Innovator in Translation Inhibition

Introduction

Amarnath Natarajan is a distinguished inventor based in Texas City, TX. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit translation initiation. With a total of six patents to his name, Natarajan's work has the potential to impact various medical applications.

Latest Patents

Natarajan's latest patents include innovative compositions and methods for inhibiting translation using 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and its derivatives. These patents describe compositions, methods, and kits for treating cellular proliferative disorders, non-proliferative degenerative disorders, viral infections, and disorders associated with viral infections. His research focuses on the use of 3-(5-tert-butyl-2-hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and its derivatives as effective therapeutic agents.

Career Highlights

Amarnath Natarajan is affiliated with Harvard College, where he continues to advance his research in the field of biochemistry. His work has garnered attention for its potential applications in treating various health conditions. Natarajan's innovative approach to translation inhibition has positioned him as a key figure in his area of expertise.

Collaborations

Natarajan has collaborated with notable colleagues, including José A Halperin and Yun-Hua Fan. These partnerships have contributed to the advancement of his research and the development of new therapeutic strategies.

Conclusion

Amarnath Natarajan is a prominent inventor whose work in translation inhibition holds promise for addressing significant medical challenges. His contributions to the field are marked by a commitment to innovation and collaboration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…